Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 24, 1999

View Archived Issues

SR Pharma Enters Deal With Sakai, Completes

Rearranged Telomeres May Be A Link To Mental Retardation

Irish Biotechnology Sector Facing Famine In Financing

EC Seeks Broader Support For Positions At World Trade Talks

genOway Seeks To Accelerate Genetics-Based Development

XTL Partners With Roche To Test Hepatitis C Drug

Cyclacel Recipient Of Fund To Boost Scottish Biotech

Canadian Scientists Find A Trigger For Bone Destruction

Other News To Note

Scotia Gains Orphan Status For Photodynamic Therapy

IDM Opens New Laboratory On Site Of Paris University

Oxford Glycosciences Finds Differences In Two Cell Types

Otogene Getting Funding To Develop Hearing Loss Drugs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...